Gian Life Care Ltd Stock Price Today (NSE: GIANLIFE)
Fundamental Score
Gian Life Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Gian Life Care Ltd share price today is ₹6.14, up +3.50% on NSE/BSE as of 30 March 2026. Gian Life Care Ltd (GIANLIFE) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹10.98 (Cr). The 52-week high for GIANLIFE share price is ₹18.71 and the 52-week low is ₹5.96. The company has a Return on Equity (ROE) of -0.21% and a debt-to-equity ratio of 0.30.
Gian Life Care Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Gian Life Care Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Gian Life Care Share Price Analysis: A Growth Strategist's Perspective
In the fragmented and competitive healthcare service provider landscape, building a strong brand and efficient operations is crucial for sustained success. This analysis examines the financial standing of Gian Life Care Ltd, focusing on its potential for industry dominance through the lens of its current share price. The current Gian Life Care share price stands at ₹10.09, accompanied by a notable absence of a Price-to-Earnings (PE) ratio and a Return on Capital Employed (ROCE) of 2.4%. This preliminary data suggests a need for in-depth investigation before formulating any growth strategy.
A critical comparison with its peers, such as Suraksha Diagnostic Ltd, Aspira Pathlab & Diagnostics Limited, and Samsrita Labs Ltd, is essential. While a complete management quality assessment requires comprehensive data, comparing Gian Life Care Ltd with
Suraksha Diagnostic Ltd could offer insight on how effective leadership impacts ROCE and overall market perception. Different managerial styles and business execution skills can create competitive advantages.The ROCE of 2.4% warrants particular attention. A low ROCE directly impacts the company's economic moat, its ability to defend its market share and generate consistent profits. With a ROCE of 2.4%, Gian Life Care Ltd demonstrates the need to improve how well capital is allocated to earn a profit. A strong competitive advantage that sustains pricing power can't be built with such a low return on capital.
It's important to note that this financial overview is an excerpt from a more comprehensive 80-parameter fundamental audit. This analysis, verified by Sweta Mishra, offers observations based on publicly available data, providing a high-level perspective on the company's financial position. This is intended for informational purposes and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Gian Life Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GIANLIFE across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Risk Factors
7 factors identified
Below-Average Return on Equity (-0.21%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (2.40%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-44.44%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-56.06%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Interest Coverage (0.93x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
High Share Pledging Risk (61.17%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Gian Life Care Ltd Financial Statements
Comprehensive financial data for Gian Life Care Ltd including income statement, balance sheet and cash flow
About GIANLIFE (Gian Life Care Ltd)
Gian Life Care Ltd is a burgeoning healthcare service provider dedicated to revolutionizing diagnostics and wellness solutions. With a foundation built on precision and patient-cen...tricity, GIANLIFE strives to empower individuals to take proactive control of their health. The company operates under the core belief that accurate and timely diagnostics are paramount for effective healthcare management. Through a comprehensive suite of services, GIANLIFE serves as a trusted partner for patients, medical professionals, and organizations seeking reliable insights into health status. Their commitment extends beyond mere testing, embracing a holistic approach to preventative care and personalized wellness strategies. Located in India, GIANLIFE endeavours to cater to the evolving healthcare needs of the local community. At the heart of GIANLIFE lies a diverse portfolio of diagnostic tests, spanning crucial areas of medical science. From advanced biochemistry and clinical pathology to intricate cytogenetic and cytology analyses, GIANLIFE offers a broad spectrum of testing options. These services are designed to uncover a wealth of information, aiding in the early detection, diagnosis, and monitoring of various health conditions. Employing cutting-edge technology and rigorous quality control measures, GIANLIFE ensures the accuracy and reliability of its results. The company's expert team of professionals diligently interprets the data, providing comprehensive reports that inform clinical decision-making. GIANLIFE is committed to serving a diverse clientele, including individual patients seeking clarity about their health, healthcare providers looking for dependable diagnostic support, and corporate entities invested in employee well-being. By delivering efficient and accessible services, GIANLIFE aims to contribute to the overall health and prosperity of the community. From routine check-ups to specialized investigations, the company caters to a wide array of healthcare needs. With a focus on fostering trust and delivering exceptional service, GIANLIFE strives to be a beacon of excellence in the Indian healthcare landscape.
Company Details
Key Leadership
GIANLIFE Share Price: Frequently Asked Questions
What is the current share price of Gian Life Care Ltd (GIANLIFE)?
As of 30 Mar 2026, 12:03 pm IST, Gian Life Care Ltd share price is ₹6.14. The GIANLIFE stock has a market capitalisation of ₹10.98 (Cr) on NSE/BSE.
Is GIANLIFE share price Overvalued or Undervalued?
GIANLIFE share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 39.28x. Based on this relative valuation, the Gian Life Care Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of GIANLIFE share price?
The 52-week high of GIANLIFE share price is ₹18.71 and the 52-week low is ₹5.96. These values are updated daily from NSE/BSE price data.
What factors affect the Gian Life Care Ltd share price?
Key factors influencing GIANLIFE share price include quarterly earnings growth (Sales Growth: -56.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Gian Life Care Ltd a good stock for long-term investment?
Gian Life Care Ltd shows a 5-year Profit Growth of N/A% and an ROE of -0.21%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.30 before investing in GIANLIFE shares.
How does Gian Life Care Ltd compare with its industry peers?
Gian Life Care Ltd competes with major peers in the Healthcare Service Provider. Investors should compare GIANLIFE share price P/E of 0.00x and ROE of -0.21% against the industry averages to determine competitive standing.
What is the P/E ratio of GIANLIFE and what does it mean?
GIANLIFE share price has a P/E ratio of N/Ax compared to the industry average of 39.28x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is GIANLIFE performing according to Bull Run's analysis?
GIANLIFE has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does GIANLIFE belong to?
GIANLIFE operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Gian Life Care Ltd share price.
What is Return on Equity (ROE) and why is it important for GIANLIFE?
GIANLIFE has an ROE of -0.21%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Gian Life Care Ltd generates profits from shareholders capital.
How is GIANLIFE debt-to-equity ratio and what does it indicate?
GIANLIFE has a debt-to-equity ratio of 0.30, which indicates conservative financing with low financial risk.
What is GIANLIFE dividend yield and is it a good dividend stock?
GIANLIFE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Gian Life Care Ltd shares.
How has GIANLIFE share price grown over the past 5 years?
GIANLIFE has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GIANLIFE and why does it matter?
Promoters hold 32.09% of GIANLIFE shares, with 61.17% pledged. High promoter holding often indicates strong management confidence in Gian Life Care Ltd.
What is GIANLIFE market capitalisation category?
GIANLIFE has a market capitalisation of ₹11 crores, placing it in the Small-cap category.
How volatile is GIANLIFE stock?
GIANLIFE has a beta of N/A. A beta > 1 suggests the Gian Life Care Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is GIANLIFE operating profit margin trend?
GIANLIFE has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is GIANLIFE quarterly performance?
Recent quarterly performance shows Gian Life Care Ltd YoY Sales Growth of -56.06% and YoY Profit Growth of -44.44%.
What is the institutional holding pattern in GIANLIFE?
GIANLIFE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Gian Life Care Ltd stock.